Molecular Genetics and Metabolism Reports (Dec 2020)

Arginine kinetics are altered in a pilot sample of adolescents and young adults with Barth syndrome

  • W. Todd Cade,
  • Kathryn L. Bohnert,
  • Adam J. Bittel,
  • Shaji J. Chacko,
  • Bruce W. Patterson,
  • Christina A. Pacak,
  • Barry J. Byrne,
  • Hilary J. Vernon,
  • Dominic N. Reeds

Journal volume & issue
Vol. 25
p. 100675

Abstract

Read online

Barth syndrome (BTHS) is a rare, X-linked cardiomyopathy that is characterized by abnormalities in glucose and lipid metabolism, with less known regarding amino acid metabolism. This pilot study characterized whole-body arginine kinetics and found lower arginine rate of appearance into plasma (0.69 ± 0.09 vs. 0.88 ± 0.06 μmol/kgFFM/min, p < 0.01) and arginine non-oxidative disposal rate (0.64 ± 0.11 vs. 0.80 ± 0.03 μmol/kgFFM/min, p < 0.02) in adolescents and young adults with BTHS compared to Controls. This study provides a foundation for more in-depth studies on how arginine and potentially other amino acid abnormalities contribute to the pathology and clinical manifestations of BTHS.

Keywords